Elixinol Wellness Limited
ELLXF
$0.01
$0.01248.78%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.12% | -10.11% | |||
| Total Other Revenue | 2.78% | -- | |||
| Total Revenue | 2.12% | -9.84% | |||
| Cost of Revenue | 2.12% | -7.96% | |||
| Gross Profit | 2.12% | -13.19% | |||
| SG&A Expenses | 2.12% | 8.72% | |||
| Depreciation & Amortization | 2.12% | -2.55% | |||
| Other Operating Expenses | 2.14% | -15.12% | |||
| Total Operating Expenses | 2.12% | -0.98% | |||
| Operating Income | -2.12% | -29.05% | |||
| Income Before Tax | -2.12% | -16.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.12% | -387.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.12% | -387.95% | |||
| EBIT | -2.12% | -29.05% | |||
| EBITDA | -2.12% | -28.51% | |||
| EPS Basic | -2.27% | -344.44% | |||
| Normalized Basic EPS | -3.23% | -10.71% | |||
| EPS Diluted | -2.27% | -344.44% | |||
| Normalized Diluted EPS | -3.23% | -10.71% | |||
| Average Basic Shares Outstanding | 0.00% | 20.50% | |||
| Average Diluted Shares Outstanding | 0.00% | 20.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||